Betaine-Homocysteine Methyltransferase (BHMT): Genomic Sequencing and Relevance to Hyperhomocysteinemia and Vascular Disease in Humans
Authors:
- Karin J.A. LieversKLKarin J.A. Lievers
- Godfried H. BoersGBGodfried H. Boers
- Petra VerhoefPVPetra Verhoef
- Martin Den HeijerMHMartin Den Heijer
- Frans J.M. TrijbelsFTFrans J.M. Trijbels
- Henk J. BlomHBHenk J. Blom
- 1 November 2000
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 71 (3) , 511-519
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrationsGenetic Epidemiology, 1999
- Recombinant Human Liver Betaine-homocysteine S-Methyltransferase: Identification of Three Cysteine Residues Critical for Zinc BindingBiochemistry, 1999
- Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular diseaseQJM: An International Journal of Medicine, 1997
- Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1997
- Purification, Kinetic Properties, and cDNA Cloning of Mammalian Betaine-Homocysteine MethyltransferaseJournal of Biological Chemistry, 1996
- Hyperhomocysteinemia as a Risk Factor for Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985
- Betaine, metabolic by-product or vital methylating agent?Life Sciences, 1983